Cresco Labs (OTCMKTS:CRLBF – Get Free Report) was upgraded by stock analysts at Cormark from a “hold” rating to a “moderate ...

Equities research analysts at Alliance Global Partners lifted their Q3 2025 earnings per share estimates for shares of Cresco ...

Its fourth quarter results are in the books and Roth analyst Bill Kirk still thinks there is money to be made on Cresco Labs ...

Explore Cresco Labs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRLBF. Cannabis Firm Cresco Labs Reports Mixed Q4, CEO Says Company Will ...

Cresco Labs Q4 revenue is $175.91M, surpassing estimates of $172.13M. Adjusted EBITDA hit $42M with a 24% margin. Gross margin drops to 47.8% from 51.1%, while operating profit declines to $19.41M ...

Cresco Labs and Progressive Treatment Solutions. Under state law, cannabis-infused products, or edibles, cannot exceed 100 ...

Alliance Global Partners analyst Aaron Grey lowered the firm’s price target on Cresco Labs (CRLBF) to C$3.25 from C$3.50 and keeps a Buy rating on the shares. Published first on TheFly – the ...

Q4 2024 Earnings Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsTJ Cole - Senior Vice President, ...

Alliance Global Partners lowered the firm’s price target on Cresco Labs (CRLBF) to C$3.25 from C$3.50 and keeps a Buy rating on the shares following the Q4 report. The company’s initiatives ...